NantHealth Inc
NASDAQ:NH
NantHealth Inc
NASDAQ:NH
Price:
0.4219 USD
4.12%
Market Closed
Updated:
May 4, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of NH.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NH
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
NH Competitors Multiples
NantHealth Inc Competitors
NantHealth Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
NantHealth Inc
NASDAQ:NH
|
3.3m USD | 0 | -0 | -9.3 | -6.4 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.8B USD | 13.9 | 62.4 | 62.3 | 67 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.9B AUD | 81.1 | 170.1 | 117 | 117 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7.4B USD | 11.8 | -349 | -184.9 | -171.9 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 4.8 | 24.1 | 12.5 | 14.1 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 9.6 | 32.6 | 21.8 | 23.2 | |
| SE |
|
Sectra AB
STO:SECT B
|
42.6B SEK | 26 | 100.4 | -66.1 | -66.1 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -21.7 | 25.6 | 272.8 | |
| US |
|
Certara Inc
NASDAQ:CERT
|
2.8B USD | 7.9 | -50.8 | 46 | 461.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
